Literature DB >> 12633796

Effects of operator experience on the outcome and duration of pulmonary vein isolation procedures for atrial fibrillation.

Bradley P Knight1, Hakan Oral, Aman Chugh, Christoph Scharf, Steve W K Lai, Frank Pelosi, S Adam Strickberger, Fred Morady.   

Abstract

Segmental, ostial ablation to isolate the pulmonary veins has been shown to be effective for the treatment of atrial fibrillation (AF). The purpose of this study was to determine the effects of operator experience on the outcome and duration of pulmonary vein isolation procedures for AF. One hundred three consecutive patients with AF underwent segmental, ostial ablation to isolate pulmonary veins. The effect of operator experience on the outcome and duration of the procedure was measured. The mean procedure duration was 232 +/- 70 minutes (range 50 to 460). There was an indirect linear relation between the total procedure time and the number of procedures performed (r = -0.68; p <0.001), and between the total fluoroscopic time and the number of procedures performed (r = -0.71; p <0.001). The percentage of patients in whom complete isolation of the pulmonary veins was achieved and the total duration of radiofrequency energy delivered during the procedures remained stable as operator experience increased. Operator experience was not an independent predictor of recurrent AF. The primary effect of operator experience on pulmonary vein isolation procedures for AF was a marked reduction in the duration of the procedure and fluoroscopic time. Long procedure durations and large amounts of radiation exposure may currently limit the widespread application of this therapy. The results of this study suggest that after >75 cases, segmental ablation to isolate the pulmonary veins using fluoroscopy and conventional radiofrequency ablation usually is feasible in <3 hours.

Entities:  

Mesh:

Year:  2003        PMID: 12633796     DOI: 10.1016/s0002-9149(02)03402-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Hubble, bubble, toil and trouble..: Which way in PV ablation?

Authors:  T A Simmers
Journal:  Neth Heart J       Date:  2005-12       Impact factor: 2.380

2.  No severe pulmonary vein stenosis after extensive encircling pulmonary vein isolation: 12-month follow-up with 3D computed tomography.

Authors:  Shingo Maeda; Yoshito Iesaka; Kiyoshi Otomo; Kikuya Uno; Yasutoshi Nagata; Kenji Suzuki; Hitoshi Hachiya; Masahiko Goya; Atsushi Takahashi; Hideomi Fujiwara; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2010-12-04       Impact factor: 2.037

3.  Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients.

Authors:  J P Bourke; A Dunuwille; D O'Donnell; S Jamieson; S S Furniss
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

4.  Survey of physician experience, trends and outcomes with atrial fibrillation ablation.

Authors:  Steven Mickelsen; Ben Dudley; Eric Treat; John Barela; John Omdahl; Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2005-04       Impact factor: 1.900

5.  Atrial fibrillation: Preventing serious complications during AF ablation.

Authors:  Aman Chugh; Hakan Oral
Journal:  Nat Rev Cardiol       Date:  2009-09       Impact factor: 32.419

6.  Inner lumen mapping catheter-facilitated big cryoballoon treatment for atrial fibrillation shortens procedural duration and fluoroscopic exposure with comparable mid-term efficacy.

Authors:  Ngai-Yin Chan; Ho-Chuen Yuen; Pui-Shan Chu; Chi-Chung Choy; Hoi-Fan Chow; Ho-Fai Fong; Chun-Leung Lau; Ying-Keung Lo; Ping-Tim Tsui; Suet-Ting Lau; Ngai-Shing Mok
Journal:  J Interv Card Electrophysiol       Date:  2013-03-19       Impact factor: 1.900

7.  Catheter ablation for atrial fibrillation.

Authors:  Andre J Gauri; Bradley P Knight
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

Review 8.  New Technologies In Atrial Fibrillation Ablation.

Authors:  John Rickard Md Mph; Saman Nazarian Md Phd
Journal:  J Atr Fibrillation       Date:  2014-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.